# US 2021/0146031 A1 · Systems and methods for monitoring and controlling fluid balance during a biological fluid procedure

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0146031 A1
- Document ID: US20210146031A1
- Status: Published application
- Kind: A1
- Application number: 17/162,217
- Filed: 2021-01-29
- Published: 2021-05-20
- Earliest claimed: 2017-10-02
- Assignees: Fenwal, Inc.
- Applicants: Fenwal, Inc.
- Inventors: Zahra R. Ali; Lan T. Nguyen
- Web page: https://patentgrep.com/patent/US20210146031A1

## CPC

- A61M 1/3607: {Regulation parameters}
- A61M 1/0209: {Multiple bag systems for separating or storing blood components}
- A61M 1/361: {before treatment}
- A61M 1/36225: {with blood pumping means or components thereof}
- A61M 1/3643: {Priming, rinsing before or after use}
- A61M 1/3672: {Means preventing coagulation}
- A61M 1/3683: {using photoactive agents}
- A61M 1/3693: {using separation based on different densities of components, e.g. centrifuging}
- A61M 1/3696: {with means for adding or withdrawing liquid substances during the centrifugation, e.g. continuous centrifugation}
- A61M 1/38: Removing constituents from donor blood and {storing or} returning remainder to body {, e.g. for transfusion}
- A61M 1/362266: {Means for adding solutions or substances to the blood}
- A61M 2202/0092: starting product created by centrifuging
- A61M 2202/0407: Lymphocytes
- A61M 2202/0413: Blood
- A61M 2202/0415: Plasma
- A61M 2202/0429: Red blood cells; Erythrocytes
- A61M 2202/0439: White blood cells; Leucocytes
- A61M 2202/0443: Macrophages, e.g. monocytes
- A61M 2205/3386: Low level detectors
- A61M 2205/50: with microprocessors or computers
- A61M 2230/005: Parameter used as control input for the apparatus
- A61M 2230/207: hematocrit
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}

## Abstract

An extracorporeal photopheresis system includes a separator with a disposable fluid circuit including a treatment container, an irradiation device configured to treat the contents of the treatment container, and a controller configured to control the system to perform a procedure including drawing anticoagulated whole blood into the fluid circuit from a blood source and returning to the blood source a treated target cell component, a portion of a red blood cell component remaining in the fluid circuit, and/or a portion of a plasma component remaining in the fluid circuit. The controller is further configured to estimate an end-of-procedure fluid balance estimated based on manual or automatic inputs including a patient body weight associated with the blood source and a total blood volume of the blood source, indicate the fluid balance to an operator, and receive one or more changes that affect the fluid balance after indicating the fluid balance.

## Claims

### Claim 1

An extracorporeal photopheresis system, comprising:
a separator configured to work in association with a disposable fluid circuit comprising a treatment container, the separator comprising a chamber configured to rotate about a rotational axis and convey whole blood from a blood source into an inlet region of the chamber for separation into a red blood cell component, a plasma component, and the target cell component;
an irradiation device configured to treat the contents of the treatment container; and
a microprocessor-based controller in communication with the separator, wherein the controller is configured to control the system to perform a procedure, the procedure including to draw anticoagulated whole blood into the disposable fluid circuit and the chamber at a whole blood flow rate, to separate the anticoagulated whole blood into the red blood cell component, the target cell component, and the plasma component, to direct the target cell component to the treatment container, to treat the treatment container comprising the target cell component to create a treated target cell component, and to return to the blood source the treated target cell component, a portion of the red blood cell component remaining in the fluid circuit, and/or a portion of the plasma component remaining in the fluid circuit,
wherein the microprocessor-based controller is further configured to:
estimate an end-of-procedure fluid balance, wherein the end-of-procedure fluid balance is estimated based on manual or automatic inputs comprising a patient body weight associated with the blood source and a total blood volume of the blood source,
indicate the end-of-procedure fluid balance to an operator, and
receive one or more changes that affect the end-of-procedure fluid balance after indicating the end-of-procedure fluid balance.

### Claim 2 (depends on 1)

The system according to claim 1, wherein the controller is configured to display the end-of-procedure fluid balance to the operator on an integrated input/output terminal.

### Claim 3 (depends on 1)

The system according to claim 1, wherein the controller is further configured to calculate the total volume of the blood source with information comprising a patient gender, a patient height, and the patient body weight of the blood source.

### Claim 4 (depends on 1)

The system according to claim 1, wherein the procedure includes adding anticoagulant solution, and the controller is further configured to estimate the end-of-procedure fluid balance, in part, by calculating a total volume of the anticoagulant solution having a citrate concentration to be used for the procedure.

### Claim 5 (depends on 4)

The system according to claim 4, wherein the end-of-procedure fluid balance is estimated based on manual or automatic inputs comprising an ACD ratio relating unanticoagulated extracorporeal whole blood to the anticoagulant solution, an amount of whole blood to process, and a citrate infusion threshold rate.

### Claim 6 (depends on 5)

The system according to claim 5, wherein the controller is further configured to estimate a maximum extracorporeal volume of red blood cells during the procedure based on the ACD ratio, a hematocrit of the blood source, a hematocrit of a priming fluid, and the total blood volume.

### Claim 7 (depends on 5)

The system according to claim 5, wherein the controller is further configured to calculate the total volume of anticoagulant solution to be used for the procedure based on the whole blood flow rate calculated based on manual or automatic inputs comprising the ACD ratio, the citrate infusion threshold rate, and the patient body weight associated with the blood source.

### Claim 8 (depends on 5)

The system according to claim 5, wherein the end-of-procedure fluid balance is further estimated based on a volume of fluid not returning to the blood source.

### Claim 9

A method of performing an extracorporeal photopheresis procedure using a microprocessor-based controller in communication with a separator and an irradiation device, the separator configured to work in association with a disposable fluid circuit comprising a treatment container, the separator comprising a chamber configured to rotate about a rotational axis and convey whole blood from a blood source into an inlet region of the chamber for separation into a red blood cell component, a plasma component and the target cell component and the irradiation device configured to treat the contents of the treatment container, the method comprising:
drawing anticoagulated whole blood into the disposable fluid circuit and the chamber at a whole blood flow rate,
separating the anticoagulated whole blood into the red blood cell component, the target cell component, and the plasma component,
directing the target cell component to the treatment container,
treating the treatment container comprising the target cell component to create a treated target cell component,
returning to the blood source the treated target cell component, a portion of the red blood cell component remaining in the fluid circuit, and/or a portion of the plasma component remaining in the fluid circuit,
estimating an end-of-procedure fluid balance, wherein the end-of-procedure fluid balance is estimated based on manual or automatic inputs comprising a patient body weight associated with the blood source and a total blood volume of the blood source,
indicating the end-of-procedure fluid balance to an operator, and
receiving one or more changes that affect the end-of-procedure fluid balance after indicating the end-of-procedure fluid balance.

### Claim 10 (depends on 9)

The method according to claim 9, further comprising displaying the end-of-procedure fluid balance to the operator on an integrated input/output terminal.

### Claim 11 (depends on 9)

The method according to claim 9, further comprising calculating the total volume of the blood source with information comprising a patient gender, a patient height, and the patient body weight of the blood source.

### Claim 12 (depends on 9)

The method according to claim 9, further comprising adding anticoagulant solution, and wherein the end-of-procedure fluid balance is estimated, in part, by calculating a total volume of the anticoagulant solution having a citrate concentration to be used for the procedure.

### Claim 13 (depends on 12)

The method according to claim 12, wherein the end-of-procedure fluid balance is estimated based on manual or automatic inputs comprising an ACD ratio relating unanticoagulated extracorporeal whole blood to the anticoagulant solution, an amount of whole blood to process, and a citrate infusion threshold rate.

### Claim 14 (depends on 13)

The method according to claim 13, further comprising estimating a maximum extracorporeal volume of red blood cells during the procedure based on the ACD ratio, a hematocrit of the blood source, a hematocrit of a priming fluid, and the total blood volume.

### Claim 15 (depends on 13)

The method according to claim 13, further comprising calculating the total volume of anticoagulant solution to be used for the procedure based on the whole blood flow rate calculated based on manual or automatic inputs comprising the ACD ratio, the citrate infusion threshold rate, and the patient body weight associated with the blood source.

### Claim 16 (depends on 13)

The method according to claim 13, wherein the end-of-procedure fluid balance is further estimated based on a volume of fluid not returning to the blood source.
